Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Clinical trial NCT03137121 · COMPLETED
Trial details
- NCT number
- NCT03137121
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2019-07-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.